Mcl1-IN-5
Mcl1-IN-5 (compound 21) is a MCL-1 inhibitor. Mcl1-IN-5 can be used for the research of cancers[1].
Product Specifications
CAS Number
[2056238-04-9]
UNSPSC
12352005
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mcl1-in-5.html
Solubility
10 mM in DMSO
Smiles
O=C1N(C2)C3=CC=CC=C3CC[C@]1([H])NC(C[C@H](NCCCN(C)C(C[C@H](CC4=CC(CCC5=CC=CC=C5)=C(Cl)C=C4)NC2=O)=O)CC6=CC=C(S(C)(=O)=O)C=C6)=O
Molecular Formula
C45H52ClN5O6S
Molecular Weight
826.44
References & Citations
[1]Johannes JW, et al. Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors [published correction appears in ACS Med Chem Lett. 2017 Oct 18;8 (11) :1204]. ACS Med Chem Lett. 2016;8 (2) :239-244.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal CEACAM1/CD66a Antibody (CC1) [DyLight 650]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
MBS1416227-01 0.02 mg (E-Coli)
Recombinant Synechococcus sp. Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details 
MBS1416227-02 0.1 mg (E-Coli)
Recombinant Synechococcus sp. Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details MBS1416227-03 0.02 mg (Yeast)
Recombinant Synechococcus sp. Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details 
MBS1416227-04 0.1 mg (Yeast)
Recombinant Synechococcus sp. Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details MBS1416227-05 0.02 mg (Baculovirus)
Recombinant Synechococcus sp. Probable nicotinate-nucleotide adenylyltransferase (nadD)
Ask
View Details